Placement of an implantable cardioverter-defibrillator in an infant with congenital long QT syndrome: Anesthetic considerations

Kansara, Bhuvnesh; Singh, Ajmer; Kaushal, Sunil; Saxena, Anil

doi:10.4103/0971-9784.81568

Cited by 3 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…have successfully given general anesthesia for the placement of an implantable cardioverter-defibrillator in an infant with congenital long QT syndrome with similar history. [ 4 ] The ICD has an important role for SCD prevention in children and adolescents. [ 5 ] Patients with previous history of cardiac arrest and two or more risk factors should be considered for an ICD implantation.…”

Section: Discussionmentioning

confidence: 99%

Anesthesia in a child with newly diagnosed hypertrophic cardiomyopathy for placement of implantable cardioverter defibrillator

Kumar¹,

Kumari²

2018

Anesth Essays Res

View full text Add to dashboard Cite

Hypertrophic cardiomyopathy (HCM) is a genetic myocardial disease usually characterized by asymmetric ventricular septal hypertrophy. HCM is an important cause of sudden cardiac death in adolescents and young adults. We are presenting a case report, ten years boy came in emergency with sudden loss of consciousness (witness cardiac arrest). Child was revived after cardiopulmonary resuscitation and send to coronary care unit. Echocardiography findings were suggestive of HCM. There was history of sudden death of her mother and maternal uncle. After stabilization ICD was implanted under total intravenous anesthesia. Post procedure his hospital stay was uneventful.

show abstract

Section: Discussionmentioning

confidence: 99%

Anesthesia in a child with newly diagnosed hypertrophic cardiomyopathy for placement of implantable cardioverter defibrillator

Kumar¹,

Kumari²

2018

Anesth Essays Res

View full text Add to dashboard Cite

show abstract

“…In addition to the reports supporting its safety, [17,18] there are also some concerns regarding regeneration of malignant arrhythmias. [14][15][16] There are several case reports showing the development of intraoperative TdP episodes during sevoflurane anesthesia.…”

Section: Discussionmentioning

confidence: 99%

“…In their case report, Kansara et al [17] reported the anesthetic considerations in an infant with LQTS. They used sevoflurane not only for induction, but also for maintenance of anesthesia without any adverse effect, considering that sevoflurane has minor effects on cardiac electrophysiology.…”

Section: Discussionmentioning

confidence: 99%

Torsade de Pointes during placement of an implantable cardioverter-defibrillator in a child with long QT syndrome

Gökay¹

2016

Turk Gogus Kalp Dama

View full text Add to dashboard Cite

ÖZUzun QT sendromu, Torsade de Pointes başta olmak üzere, ventriküler taşiaritmilere yatkınlığa neden olan, QT aralığında uzama ile karakterizedir. QT aralığının uzamasından inhaler anestetikler sorumlu tutulmaktadır. Bu yazıda, implante edilebilir kardiyoverter-defibrilatör yerleştirme cerrahisi sırasında sevofluran ile genel anestezide iken inatçı Torsade de Pointes atağı geçiren uzun QT sendromlu bir pediatrik olgu sunuldu. Elektriksel kardiyoversiyon gerektiren tekrarlayan Torsade de Pointes ataklarının cerrahi tedavi ile ilişkili olmadığı düşünüldü. Bu ataklar sevofluran inhalasyonu ile ilişkilendirildi. Sevofluran sonlandırıldıktan sonra, aritmiler ortadan kayboldu. Malign aritmiler hastalar için tehlikeli sonuçlar doğurabileceği için, uzun QT sendromlu hastalarda inhaler anestetiklerin kullanılmaması gerektiği kanısındayız.Anah tar söz cük ler: Aritmi; uzun QT sendromu; sevofluran. ABSTRACTLong QT syndrome is characterized by a prolongation of the QT interval resulting in a tendency to ventricular tachyarrhythmias, particularly Torsade de Pointes. Inhalational anesthetics are often accused of prolonged QT interval. Herein, we report a pediatric case of long QT syndrome with a persistent Torsade de Pointes episode under general anesthesia with sevoflurane during surgical implantable cardioverter-defibrillator placement. Recurrent Torsade de Pointes requiring electrical cardioversion were considered to be unrelated to the surgical management. These episodes were considered to be related to sevoflurane inhalation. After terminating sevoflurane, arrhythmias disappeared. As malignant arrhythmias may have detrimental results for patients, we conclude that inhalation anesthetics should be avoided in patients with long QT syndrome.

show abstract

Anesthetic Considerations for Pediatric Patients With Congenital Long QT Syndrome

Staudt

Watkins

2019

Journal of Cardiothoracic and Vascular Anesthesia

View full text Add to dashboard Cite

Placement of an implantable cardioverter-defibrillator in an infant with congenital long QT syndrome: Anesthetic considerations

Cited by 3 publications

References 19 publications

Anesthesia in a child with newly diagnosed hypertrophic cardiomyopathy for placement of implantable cardioverter defibrillator

Anesthesia in a child with newly diagnosed hypertrophic cardiomyopathy for placement of implantable cardioverter defibrillator

Torsade de Pointes during placement of an implantable cardioverter-defibrillator in a child with long QT syndrome

Anesthetic Considerations for Pediatric Patients With Congenital Long QT Syndrome

Contact Info

Product

Resources

About